epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System, SMN 10736515

FDA Device Recall #Z-0286-2025 — Class II — September 24, 2024

Recall Summary

Recall Number Z-0286-2025
Classification Class II — Moderate risk
Date Initiated September 24, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Siemens Healthcare Diagnostics Inc
Location Norwood, MA
Product Type Devices
Quantity 1292 units

Product Description

epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System, SMN 10736515

Reason for Recall

Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in one lot of epoc BGEM BUN Test Cards approximately 2 months prior to expiration. The observed maximum negative bias from internal testing is -10 mmol/L. No positive bias has been observed. Quality Control (QC) fluid may or may not detect the issue depending on the bias magnitude and the frequency of QC testing. One customer complaint has been associated with this issue. No adverse events have been reported. All affected lots have recently expired before the issuance of the recall.

Distribution Pattern

US Nationwide. Canada.

Lot / Code Information

UDI-DI: 00809708121860; Lot Numbers: 08-24092-60 08-24093-60 08-24094-60 08-24095-60 08-24096-60

Other Recalls from Siemens Healthcare Diagnostics Inc

Recall # Classification Product Date
Z-2272-2025 Class II epoc BGEM BUN Test Card [25pk]. Material Number... Jul 7, 2025
Z-2230-2025 Class II RAPIDPoint 500 Systems Wash/Waste Cartridge (4 ... Jun 26, 2025
Z-1673-2025 Class II Stratus CS Acute Care cTNI TestPak.IVD test for... Mar 31, 2025
Z-1684-2025 Class II epoc BGEM BUN Test Card (25 pk) for the epoc Bl... Mar 19, 2025
Z-1685-2025 Class II epoc BGEM Crea Test Card (25 pk) for the epoc B... Mar 19, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.